Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A Systematic Literature Review of the Economic and Healthcare Resource Utilization Burden of Relapsed/Refractory Follicular Lymphoma.
Journal: PharmacoEconomics - open
Published: March 25, 2025
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study.
Journal: The Lancet. Haematology
Published: August 22, 2023
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
Journal: JAMA network open
Published: June 05, 2023
Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center.
Journal: Bone marrow transplantation
Published: December 17, 2021
How to Effectively Decrease Patient Co-Payments of High-Cost Drugs Through Innovation: Lessons From the Karmanos Specialty Pharmacy.
Journal: JCO oncology practice
Published: August 18, 2021
The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication.
Journal: PEC innovation
Published: August 06, 2021
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Journal: Blood
Published: March 24, 2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2020
Last Updated: 09/26/2026